A Trial of Linaclotide 290 μg in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Clinical trial NCT03573908 · COMPLETED
Trial details
- NCT number
- NCT03573908
- Sponsor
- Ironwood Pharmaceuticals, Inc.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2018-06-20
- Primary completion
- 2019-03-13
- Enrollment
- 614
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.